ECHO Discovery Fireside Chat: Medly Therapeutics

In December 2022, Drs. Ross and Cafazzo were named UHN’s Inventors of the Year in recognition of their development and commercialization of Medly – a remote heart failure care powered by software and artificial intelligence. Medly is also the basis of the UHN spin-off venture Medly Therapeutics, which is poised to bring heart care benefits to patients around the world.

Dr. Heather Ross is Head of the Division of Cardiology and Loretta A. Rogers Chair in Heart Function at UHN. She is Site Lead for the Ted Rogers Centre for Heart Research, Professor of Medicine at the University of Toronto and named to the Order of Canada. She is also co-lead of TRANSFORM HF.

Dr. Joe Cafazzo is the founder of Healthcare Human Factors at UHN and the holder of the inaugural Wolfond Chair in Digital Health. He is UHN’s Executive Director of Biomedical Engineering and Senior Scientist at The Centre for Digital Therapeutics. Joe is also Professor at the Institute of Health Policy, Management and Evaluation, and the Institute of Biomaterials and Biomedical Engineering.

Join us to learn more about Medly, the ingredients to a successful collaboration, and what’s expected for the future of Medly Therapeutics as it spreads, scales, and integrates new features – register for the chat today!

This Fireside Chat is part of the ECHO Discovery program, a foundational education program that explores ideation, research translation, and entrepreneurship.

ECHO Discovery is funded and organized by the Translational Biology & Engineering Program and TRANSFORM HF, at the University of Toronto and Ted Rogers Centre for Heart Research.